DeepSeek’s latest training research arrives at a moment when the cost of building frontier models is starting to choke off ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

Portfolio management, to some extent, seems more like an art to me than an exact science. Check out two of my biggest pieces ...

Gender equality was supposed to reduce gender stratification and segregation in academic and professional pursuits. Instead, ...

Perhaps it was not a coincidence that England’s best day of the series came on a rain-reduced afternoon where they were ...

Warren Buffett's decision to relinquish the chief executive role at Berkshire Hathaway marks a turning point for one of the ...

This is just one of the revelations that 79-year-old Donald Trump provided in an interview with the Wall Street Journal for a ...